Cathleen Dai

562 total citations
8 papers, 436 citations indexed

About

Cathleen Dai is a scholar working on Molecular Biology, Geriatrics and Gerontology and Epidemiology. According to data from OpenAlex, Cathleen Dai has authored 8 papers receiving a total of 436 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Geriatrics and Gerontology and 4 papers in Epidemiology. Recurrent topics in Cathleen Dai's work include Autophagy in Disease and Therapy (4 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Cathleen Dai is often cited by papers focused on Autophagy in Disease and Therapy (4 papers), Sirtuins and Resveratrol in Medicine (4 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Cathleen Dai collaborates with scholars based in Canada and United States. Cathleen Dai's co-authors include Tanveer Sharif, Shashi Gujar, Emma Martell, Barry E. Kennedy, Patrick W.K. Lee, Youra Kim, Derek R. Clements, Patrick J. Murphy, J. Patrick Murphy and Sheila K. Singh and has published in prestigious journals such as Clinical Cancer Research, Cell Death and Differentiation and Antioxidants and Redox Signaling.

In The Last Decade

Cathleen Dai

8 papers receiving 434 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cathleen Dai Canada 8 254 139 137 133 98 8 436
Emma Martell Canada 9 244 1.0× 140 1.0× 130 0.9× 122 0.9× 92 0.9× 12 419
Yan Mo China 8 341 1.3× 98 0.7× 197 1.4× 168 1.3× 112 1.1× 12 583
Shuaiyi Chen China 6 222 0.9× 90 0.6× 104 0.8× 62 0.5× 133 1.4× 6 364
Jun Young Hong United States 14 290 1.1× 138 1.0× 51 0.4× 107 0.8× 246 2.5× 23 581
Michele Aventaggiato Italy 10 183 0.7× 140 1.0× 77 0.6× 44 0.3× 104 1.1× 20 377
Wei-jie Deng China 7 336 1.3× 379 2.7× 176 1.3× 87 0.7× 40 0.4× 7 578
Seyedeh Sara Ghorbanhosseini Iran 14 263 1.0× 62 0.4× 186 1.4× 69 0.5× 61 0.6× 24 409
Fiorella Faienza Italy 8 320 1.3× 222 1.6× 137 1.0× 63 0.5× 21 0.2× 13 469
HyeRan Gwak South Korea 8 245 1.0× 78 0.6× 108 0.8× 71 0.5× 54 0.6× 10 383
Julia S. Samaddar United States 4 209 0.8× 208 1.5× 51 0.4× 55 0.4× 48 0.5× 4 346

Countries citing papers authored by Cathleen Dai

Since Specialization
Citations

This map shows the geographic impact of Cathleen Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathleen Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathleen Dai more than expected).

Fields of papers citing papers by Cathleen Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathleen Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathleen Dai. The network helps show where Cathleen Dai may publish in the future.

Co-authorship network of co-authors of Cathleen Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Cathleen Dai. A scholar is included among the top collaborators of Cathleen Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathleen Dai. Cathleen Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sharif, Tanveer, Cathleen Dai, Emma Martell, et al.. (2018). TAp73 Modifies Metabolism and Positively Regulates Growth of Cancer Stem–Like Cells in a Redox-Sensitive Manner. Clinical Cancer Research. 25(6). 2001–2017. 27 indexed citations
2.
Murphy, J. Patrick, Michael Giacomantonio, João A. Paulo, et al.. (2018). The NAD+ Salvage Pathway Supports PHGDH-Driven Serine Biosynthesis. Cell Reports. 24(9). 2381–2391.e5. 46 indexed citations
3.
Sharif, Tanveer, Emma Martell, Cathleen Dai, et al.. (2018). Regulation of Cancer and Cancer-Related Genes via NAD +. Antioxidants and Redox Signaling. 30(6). 906–923. 21 indexed citations
4.
Sharif, Tanveer, Emma Martell, Cathleen Dai, et al.. (2018). Phosphoglycerate dehydrogenase inhibition induces p-mTOR-independent autophagy and promotes multilineage differentiation in embryonal carcinoma stem-like cells. Cell Death and Disease. 9(10). 990–990. 28 indexed citations
5.
Sharif, Tanveer, Emma Martell, Cathleen Dai, et al.. (2018). HDAC6 differentially regulates autophagy in stem-like versus differentiated cancer cells. Autophagy. 15(4). 686–706. 35 indexed citations
6.
Kennedy, Barry E., Tanveer Sharif, Emma Martell, et al.. (2016). NAD+ salvage pathway in cancer metabolism and therapy. Pharmacological Research. 114. 274–283. 111 indexed citations
7.
Sharif, Tanveer, Emma Martell, Cathleen Dai, et al.. (2016). Autophagic homeostasis is required for the pluripotency of cancer stem cells. Autophagy. 13(2). 264–284. 114 indexed citations
8.
Sharif, Tanveer, Dae‐Gyun Ahn, Rong‐Zong Liu, et al.. (2015). The NAD+ salvage pathway modulates cancer cell viability via p73. Cell Death and Differentiation. 23(4). 669–680. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026